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A B S T R A C T
Background: Lung cancer screening could be a ‘teachable moment’ for behaviour change. Little is known about
how advice about smoking cessation, or other behavioural cancer risk factors, would be received in this setting.
Methods: Using a population-based survey of 459 English adults (current smokers and recent quitters aged
50–75) we assessed willingness to receive lifestyle advice (about smoking, diet, weight, physical activity, alcohol
consumption) at lung screening. Additional items assessed whether advice should be provided following ab-
normal screening results, the potential impact of advice on screening uptake, and preferred timing of advice.
Results: Overall, 64% (n= 292) of participants were willing to receive lifestyle advice at lung screening. A
greater proportion of participants were willing to receive advice in a scenario where results required further
investigation (83%; p < 0.01). However, 14% indicated the provision of lifestyle advice would make them less
willing to attend lung screening. Non-White ethnicity and greater cancer risk factor awareness were associated
with willingness to receive advice (p < 0.05). Half of smokers (51%) were willing to receive cessation advice.
There was also interest in advice about diet (47%), weight (43%), physical activity (32%), and alcohol con-
sumption (17%) among people not meeting current recommendations for these behaviours. There was a pre-
ference for advice to be delivered at the screening appointment (38%, n=108) over other time-points.
Conclusions: Lung screening may oﬀer an opportunity to provide advice about behavioural cancer risk factors.
Future work should consider how to deliver eﬀective interventions in this setting to support behaviour change,
without aﬀecting screening uptake.
1. Introduction
The European position statement on lung cancer screening re-
commends low dose computed tomography for high risk populations,
with smoking cessation advice oﬀered alongside [1]. The prevalence of
tobacco smoking ranges from 10 to 38% between European countries
[2]. In England, 17% of adults smoke [3]. However, data from lung
screening trials suggests smoking prevalence is likely to be higher
among lung screening attendees [4–6]; within the UK Lung Cancer
Screening (UKLS) pilot trial, 38.3% of the screening arm were current
smokers [4]. Tobacco is the single greatest contributor to cancer burden
in the European Union [7]. However, health behaviours tend to cluster,
meaning smokers are more likely to engage in other cancer risk beha-
viours, including increased alcohol consumption and eating an un-
healthy diet [8,9]. These modiﬁable behaviours contribute to many
non-communicable diseases including cancer, cardiovascular and
respiratory diseases, and diabetes [10]. The lung screening population
may therefore stand to beneﬁt considerably from a multiple risk factor
approach to behaviour change. Combining cancer screening and be-
haviour change advice could be cost eﬀective and provide the greatest
impact on mortality [11–13], with the addition of smoking cessation
interventions alone estimated to improve the cost eﬀectiveness of lung
screening by 20–45% [14].
Behaviour change interventions delivered within lung cancer
screening trials have focused on smoking cessation, with a recent sys-
tematic review showing tentative positive support for their im-
plementation [15,16]. To our knowledge, no research has explored the
implementation or acceptability of advice about other cancer risk fac-
tors at lung cancer screening. It is therefore important to consider the
acceptability of advice about multiple risk factors within this context.
Most people appear to be willing to receive lifestyle advice about a
range of cancer risk factors at breast, bowel and cervical screening
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[17–19]. Encouragingly, those with unhealthy behaviours appear to be
more willing to receive advice, as do those who are more aware of risk
factors for cancer [19]. However, there is concern that providing life-
style advice at cancer screening may negatively impact uptake [17].
Lung cancer screening uptake is low, particularly among current smo-
kers and socioeconomically deprived populations [20,21]. It is there-
fore important to explore preferences for advice at lung cancer
screening, as well as determinants of interest in that information to
avoid exacerbating socioeconomic inequalities further.
Using a nationally representative sample of English adults and hy-
pothetical lung screening scenarios, this research aimed to estimate the
proportion of screening intenders interested in receiving lifestyle advice
alongside lung cancer screening. We also aimed to identify determi-
nants of interest in lifestyle advice at lung cancer screening, and peo-
ple’s preferences for the timing and topics of advice.
2. Methods
2.1. Design
Data were collected using the Smoking Toolkit Study, a monthly
cross-sectional survey of smoking trends in England between May-
November 2017 (total survey n= 11,899) [22]. Face to face computer-
assisted interviews were conducted by market research agency Ipsos
MORI as part of an omnibus survey. Ethical approval was granted by
the University College London Research Ethics Committee (REF: 5210/
002), and informed consent was obtained prior to each interview.
2.2. Participants
Random location sampling was used. Quotas were set for sex, age,
working status and housing tenure to ensure a nationally representative
sample. Participants received questions relating to acceptability of
lifestyle advice at a hypothetical lung cancer screening programme
based on age and smoking history. Using UK Lung Cancer Screening
trial criteria, we included adults aged 50–75 [23]. It was not possible to
calculate individuals’ lung cancer risk, so the sample was limited to
participants who smoked, or who had quit smoking within the last 5
years. Participants were included in analyses if they stated they would
attend lung cancer screening if invited, and were excluded if they had a
previous cancer diagnosis.
2.3. Measures
Full measures are reported in Supplementary File 1. Data were
collected for four sociodemographic variables: age, gender (male / fe-
male), ethnicity (White / non-White) and educational attainment as a
marker of social position (education to degree level or above / educa-
tion below degree level).
Participants were provided with a brief description of CT lung
screening prior to questions relating to lung screening: ‘A new screening
test is being developed to ﬁnd lung cancer at an early stage. It would
use a type of x-ray called a chest CT scan. The scan takes pictures of the
lungs which are then checked for the early signs of lung cancer. The
screening test would be oﬀered to people who smoke or used to smoke,
not people going to their GP with symptoms of lung cancer.’
Intention to attend lung screening was assessed by responses to: ‘If
your GP invited you to have a lung cancer screening test as part of an
NHS lung cancer screening programme, would you take up the oﬀer?’,
dichotomised into yes (Yes, deﬁnitely; Yes, probably) and no (No,
probably not; No, deﬁnitely not).
Lung screening intenders were asked: Would you be willing to re-
ceive advice about making healthy lifestyle changes (for example, diet
or physical activity) as part of a lung screening programme?’. An ad-
ditional question assessed interest in lifestyle advice in the event of a
screening result which required further investigations: ‘Would you be
willing to receive lifestyle advice if your screening result suggested you
needed to have further investigations?’. Both responses were cate-
gorised into willing (Yes, deﬁnitely; Yes, probably), or not willing (No,
probably not; No, deﬁnitely not; Not sure). A further question asked: ‘If
you knew you would receive advice about lifestyle (for example, diet or
physical activity) as part of a lung cancer screening programme, would
this aﬀect your willingness to attend lung screening?’ (Yes, I would be
more willing to attend; Yes, I would be less willing to attend; No, it
would not aﬀect my willingness to attend).
Lung screening intenders who were willing to receive lifestyle ad-
vice at lung screening were asked about their interest in ﬁve topics: ‘If
you were to attend lung cancer screening in the future, which of the fol-
lowing, if any, would you be interested in receiving information or advice
about?.. How to have a healthy diet / maintain a healthy weight / increase
your physical activity / to stop smoking / reduce your alcohol consumption /
none of these.’ (Yes /No). One item assessed preferred timing of advice:
‘When would you prefer to receive lifestyle advice as part of a lung screening
programme?’ (before I attend the lung screening appointment; at the same
time as my screening appointment; with my screening results; 2–4 weeks
after attending screening; 1–3 months after attending screening; more than 3
months after attending screening).
Five health behaviours were assessed. Fruit and vegetable con-
sumption was measured using two items [24]: ‘Over the past month, how
many portions of fruit / vegetables did you usually eat?’. Participants who
consumed ﬁve or more portions daily were categorised as meeting
guidelines. Body Mass Index (BMI) was calculated from self-reported
height and weight. Implausible BMI data were excluded (BMI < 14
/>50). BMI was dichotomised to ≥25 (overweight) vs< 25 (not
overweight). Physical activity was assessed using one item: ‘In the past
week on how many days have you done a total of 30min or more of phy-
sical activity, which was enough to raise your breathing rate?’ [25,26].
Participants taking part in physical activity on ﬁve or more days per
week were classiﬁed as meeting guidelines. Smoking status was as-
sessed using two items: ‘Do you smoke at all nowadays?’ and ‘Did you stop
smoking completely in the last ﬁve years?’. Alcohol consumption was
measured using the AUDIT-C questionnaire [27]. Participants scoring
ﬁve or more were categorised as ‘increasing or higher risk drinkers’.
Cancer risk factor awareness was assessed using an 11-item scale
[28]. Participants were shown 11 cancer risk factors (e.g. smoking,
overweight) and were asked to select ‘Which of the following, if any, do
you personally think increase a person’s chances of developing cancer?’.
Participants were given a score out of 11.
2.4. Analyses
Descriptive analyses estimated willingness to receive information
around the time of screening, the eﬀect of information provision on
screening uptake and preferences for information timing and topics. A
McNemar’s test was used to investigate diﬀerences between interest in
advice in general, and if results would require further investigation.
Corrected Pearson Chi-squared analyses investigated diﬀerences in
proportions of people willing to receive each topic of advice by current
health behaviour. Two adjusted binary logistic regression models were
used to identify determinants of interest in advice, and determinants of
being put oﬀ attending screening if advice were delivered. Weights
were applied to unadjusted analyses to account for response bias.
Weights were calculated by Ipsos MORI using gender, age, social grade,
region, working status, housing tenure and ethnicity. Analyses were
conducted in Stata/SE 14.2.
3. Results
3.1. Sample characteristics
Of those interviewed, 685 were current smokers or recent quitters
aged 50–75. Participants were excluded from analyses if they had
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received a previous cancer diagnosis (n= 46), or indicated they would
not attend lung screening if invited (n=174); six participants met both
exclusion criteria leaving a ﬁnal sample of 459 (Table 1). The mean age
was 59.4 years. Half were male (51.4%), the majority were White
(93.9%), and educated below degree level (83.9%). Most participants
smoked (74.4%), were overweight (56.8%), and did not meet guide-
lines for fruit and vegetable consumption (63.1%) and physical activity
(60.9%). One third of participants (32.2%) were identiﬁed as increasing
or higher risk drinkers. Participants recognised an average of 3 out of
11 cancer risk factors.
3.2. Willingness to receive lifestyle advice at lung cancer screening
Two thirds (63.6%, n= 292) were willing to receive lifestyle advice
at lung cancer screening. Non-White ethnicity and greater cancer risk
factor awareness were associated with greater willingness to receive
advice at this time (Table 2). Compared with 61.5% (n= 236) of White
participants, 93.0% (n=26) of non-White participants were willing to
receive lifestyle advice at lung cancer screening, although conﬁdence
intervals were wide (OR 7.0, 95% CI 1.6–30.4, p= 0.009). Odds of
interest in advice increased with each additional cancer risk factor
identiﬁed (OR 1.10, 95% CI 1.0–1.2, p= 0.023). In a scenario where
screening required further investigations, 83.1% (n=381) indicated
they would be willing to receive lifestyle advice at lung cancer
screening. A greater proportion of people were willing to receive advice
in this scenario, compared with during lung screening in general
(McNemar’s Chi2= 123.77, p < 0.001).
3.3. Impact of lifestyle advice on intention to have lung screening
Most lung screening intenders indicated the provision of lifestyle
advice at screening would make no diﬀerence to their decision to attend
(63.2%, n= 289), or would make them more willing to attend if life-
style advice was provided (22.9%, n= 105). However, 13.9% (n=64)
of participants indicated they would be less willing to attend screening
if lifestyle advice was provided. When we dichotomised the sample into
those who would ﬁnd lifestyle advice oﬀ-putting vs. those who would
not, no determinants were found (Table 3).
3.4. Information preferences at lung cancer screening
The preferred timings for the delivery of lifestyle advice at lung
cancer screening were at the screening appointment (37.7%, n= 108),
with the screening results (30.5%, n= 87), and before the screening
appointment (17.3%, n= 50). Few people thought advice should be
provided at a later date (2–4 weeks after attending screening= 7.5%,
n=22; 1–3 months after attending screening=5.2%, n= 15; more
than three months after attending screening=1.9%, n= 5).
Of the ﬁve topics of advice, interest was highest for smoking ces-
sation (41.0%, n=422, rising to 51.0% among current smokers) and
dietary advice (40.5%, n= 118). One third of the sample were inter-
ested in advice about weight (32.4%, n=94) and physical activity
(29.0%, n= 84). One in ten participants (9.5%, n= 28) were inter-
ested in advice about alcohol consumption. Interest in advice about
smoking, diet, weight and alcohol consumption was associated with
adherence to the behaviour in question, with non-adherent people more
interested in the relevant advice (Fig. 1).
Table 1
Weighted and unweighted sociodemographic characteristics of the sample.
Unweighted (n=479) Weighted (n= 459)
n % n %
Gender
Men 246 51.4 236 51.4
Women 233 48.6 223 48.6
Ethnicity
White 450 94.3 428 93.9
Non-White 27 5.7 28 6.1
Education
Qualiﬁcations below degree level 399 83.3 385 83.9
Degree level or above 80 16.7 74 16.2
Current health behaviour
Smoking status
Current 352 73.5 341 74.4
Former 127 26.5 118 25.6
Alcohol consumption (based on
Audit-C score)
Increasing / higher risk drinker 326 31.7 147 32.2
Lower risk drinker 151 68.3 310 67.8
Weight (based on BMI)
Overweight 195 56.4 187 56.8
Normal weight 151 43.6 143 43.2
Diet (based on fruit and
vegetable consumption)
Does not meet guidelines 296 61.9 289 63.1
Meets guidelines 182 38.1 169 36.9
Physical activity
Does not meet guidelines 182 38.0 179 39.1
Meets guidelines 297 62.0 279 60.9
M SD M SD
Age 60.4 7.2 59.4 7.1
Cancer risk factor awareness 3.0 2.7 3.0 2.7
(out of a possible score of 11)
Table 2
Determinants of interest in lifestyle advice at lung cancer screening (n=474,
adjusted model).
OR (95% CI) p
Gender
Men Ref
Women 0.77 (0.52–1.13) 0.183
Ethnicity
White Ref –
Non-White 7.0 (1.6–30.4) 0.009
Education
Degree level or above Ref –
Qualiﬁcations below degree level 0.96 (0.56–1.63) 0.872
Age 0.99 (0.97–1.02) 0.663
Cancer risk factor awareness 1.10 (1.01–1.19) 0.023
Table 3
Determinants of being put oﬀ attending lung screening if lifestyle advice were
provided (n=472, adjusted model).
OR (95% CI) p
Gender
Men Ref
Women 0.62 (0.36–1.07) 0.085
Ethnicity
White Ref –
Non-White 0.92 (0.30–2.79) 0.882
Education
Degree level or above Ref –
Qualiﬁcations below degree level 1.61 (0.84–3.11) 0.154
Age 0.97 (0.93–1.01) 0.128
Cancer risk factor awareness 0.95 (0.85–1.05) 0.311
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4. Discussion
In this large, nationally representative study of people potentially
eligible for lung cancer screening, two thirds were interested in re-
ceiving lifestyle advice in this context. Previous studies have evaluated
smoking cessation advice at lung cancer screening [16], but this is the
ﬁrst study to determine interest in advice about other modiﬁable risk
factors and to explore if this could aﬀect screening attendance. Our
results suggest lung screening attenders may be interested in several
topics of advice. However, while the prospect of advice made some
participants more willing to attend; a minority of participants reported
the provision of lifestyle advice would make them less likely to attend
lung screening.
Lung cancer screening uptake is low, particularly among current
smokers and those from socioeconomically deprived populations
[20,21]. Within our sample of people who intend to attend lung
screening if invited, 14% indicated they would be less likely to parti-
cipate if they knew lifestyle advice would be provided. While a min-
ority, the potential impact that lifestyle advice may have on screening
uptake for this group is important to understand, and so re-
commendations for future research are twofold. Firstly, future research
should focus on identifying and characterising people who might be put
oﬀ attending lung screening in a real world context, and their reasons
for being deterred. We did not identify any sociodemographic de-
terminants of being deterred, although sample sizes were small
meaning associations may have been missed. Clearer insights into this
group may be found by recruiting a larger sample, or by purposively
sampling people who would be deterred by the provision of lifestyle
advice at lung screening. Secondly, future research should focus on
understanding how information and interventions can be delivered in a
way that minimises any negative eﬀects on screening uptake.
In keeping with previous research, greater cancer risk factor
awareness was positively associated with interest in lifestyle advice at
lung cancer screening [19,29]. While these data were from a cross-
sectional sample, this ﬁnding suggests that increasing awareness could
be a key aspect of engaging people with lifestyle advice within the
cancer screening context. A greater proportion of non-White partici-
pants were interested in lifestyle advice at lung screening, which has
previously been reported among non-White cervical cancer screening
intenders [17]. However, only a small proportion of our sample were
non-White highlighting the need for research with larger, more ethni-
cally diverse samples. Qualitative research may be particularly useful
tool for determining why non-White populations may be more receptive
to advice in this setting, and for understanding the information needs of
non-White lung screening attendees.
Our ﬁndings provide valuable information about preferences for
advice delivered at lung screening. Most participants wanted to receive
information close to the screening appointment (before attending,
during the appointment or with results). It may be necessary to oﬀer
information at multiple stages to appeal to diﬀerent preferences, to
reinforce messages and to promote continuity of support for behaviour
change. A greater proportion of our sample were willing to receive
lifestyle advice if their results required further investigations. Increased
smoking cessation rates have been observed among lung screening at-
tendees with abnormal results, compared with attendees with normal
screening results [30,31]. This suggests interventions may beneﬁt from
being tailored by screening result.
There is support for the implementation of smoking cessation in-
terventions within the contest of lung cancer screening, and tentative
support of the eﬃcacy of these interventions [1,16]. However, research
to date has not extended the focus of behavioural interventions at lung
screening beyond smoking cessation. Our research suggests lung
screening could be an opportunity to deliver lifestyle advice on various
topics, including diet, weight and PA. Health behaviour was associated
with interest in advice about smoking, alcohol consumption, diet and
weight, which suggests a tailored, multiple risk factor approach may be
appropriate. Interest in alcohol consumption advice was, however, low
within our sample. This is a concern as a clustering of health behaviours
means alcohol consumption is higher among smokers than non-smo-
kers, and therefore likely to be higher among lung screening attendees
[8,9]. It is important to consider how and when diﬀerent types of ad-
vice could be oﬀered to optimise their acceptability and eﬀectiveness.
This research has limitations. Hypothetical scenarios were used to
gauge interest in lifestyle advice among lung cancer screening in-
tenders. An intention-behaviour gap has been observed for other cancer
screening programmes [32,33], so it is likely that a proportion of our
sample of screening intenders may not participate in lung screening if
invited. As lung screening is not currently oﬀered in England, the
sample selected for this research may diﬀer from the population invited
to participate in lung screening if an organised programme is im-
plemented in the future. Our criteria were based on the age-range used
in a previous screening trial and smoking history, as it was not possible
to calculate lung cancer risk [23]. Therefore, our sample may not re-
present the sample eligible for an eventual UK lung screening pro-
gramme. Finally, the measures used within this study may limit our
ﬁndings. The self-report measures used to assess health behaviour may
be subject to response biases [19]. The choice and categorisation of
sociodemographic covariates, such as the dichotomisation of ethnicity
and the use of educational attainment as a marker of social position,
may explain why no sociodemographic determinants of interest in ad-
vice were identiﬁed.
5. Conclusion
Lung cancer screening may oﬀer an opportunity to provide advice
about a range of behavioural cancer risk factors which may be pre-
valent among lung screening attendees. Future work should focus on
developing eﬀective and acceptable interventions in this setting, while
ensuring strategies are aligned with those improving informed partici-
pation in lung screening.
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